NASDAQ: ILMN - Illumina

Yield per half year: -2.76%
Sector: Healthcare

Illumina

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
4/10
39.92 47.96 -16.77% 60.62 -34.15%
P/S 4.91 33.73 -85.44%
P/BV 3.85 4.81 -19.91%
P/FCF 94.2 61.71 52.65%
Ev/Ebitda -21.83 -22.5 -2.98%
Ev/S 5.18 22.53 -76.99%
Ev/FCF 83.02 68.84 20.6%
E/P -0.0439 0.0137 -421.55%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-23.73 5.15 -560.59% -10.49 126.22%
ROE -18.81 11.52 -263.26%
ROA -10.38 0.7317 -1519.11%
ROIC 6.96 7.57 -8.11%
ROS -25.8 -25.11 2.75%
ROCE -12.52 5.67 -320.56%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-2.11 -4.19 -49.52% 4.33 -148.84%
Nеt Debt/Ebitda -1.1356 -3.46 -67.17%
Debt/Ratio 0.2235 0.217 3.02%
Debt/Equity 2.07 1.7853 16.03%
Debt/Net Income -1.9466 10.36 -118.79%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.3922 -100% 0 0%
Number of years of dividend growth 0 0 0%
DSI 0 0 0%
Average dividend growth 0 0 0%
Average percentage for 5 years 0 0 0%
Average percentage for payments 78.02 43.24 80.44%
Difference from average difference in sector -1.3922 0 0%
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
4/10
27.12 59.92 -54.74%
Growth impulse Ebitda 5 years -191.37 30.17 -734.31%
Growth impulse Net Income 5 years -216.1 16.03 -1448.1%
Growth impulse FCF 5 years -66.63 27.88 -338.99%
Growth impulse EPS 5 years -209.38 44.83 -567.05%
IP Score
2.98/10

Similar companies

Nektar Therapeutics

Amarin

DENTSPLY SIRONA

ImmunoGen